Education
About Us
Working with TipRanks
Follow Us
Michel Detheux Insider Profile
4 Followers
Michel Detheux, CEO, Director at iTeos Therapeutics, holds 0.00 shares in iTeos Therapeutics (Ticker: ITOS), holds ― shares in Vor Biopharma (Ticker: VOR).
Michel Detheux iTeos Therapeutics (ITOS)CEO, Director
iTeos Therapeutics (ITOS)
CEO, Director
Not Ranked
Michel Detheux has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Michel Detheux does not currently own shares as a corporate insider.
A breakdown of Michel Detheux's holdings
Insider Roles
Director
Roles that Michel Detheux holds in companies
Most Profitable Insider Trade
Stock:
iTeos Therapeutics
(ITOS)
(ITOS)
Rating:Informative Sell
Date:Apr 19, 2022 - Apr 19, 2023
Return:+55.30%
The most profitable trade made by Michel Detheux
Michel Detheux's Trading History
iTeos Therapeutics
Aug 29, 2025
―
Uninformative Sell
―
$0.00
Vor Biopharma
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Michel Detheux's performance on stock
You May Also Like
Michel Detheux insider profile FAQ
What is the percentage of profitable transactions made by Michel Detheux?
The percentage of profitable transactions made by Michel Detheux is ―.
What is the average return per transaction made by Michel Detheux?
The average return per transaction made by Michel Detheux is ―.
What stocks does Michel Detheux hold?
Michel Detheux holds: ITOS, VOR stocks.
What was Michel Detheux’s latest transaction?
Michel Detheux latest transaction was an Uninformative Sell of ―.
What was Michel Detheux's most profitable transaction?
Michel Detheux’s most profitable transaction was an Informative Sell of ITOS stock on April 19, 2022. The return on the trade was 55.30%.
What is Michel Detheux's role in iTeos Therapeutics?
Michel Detheux's role in iTeos Therapeutics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.